Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.
This is an entirely free service. No payments are to be made.Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More
Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More
SANOFI INDIA | ABBOTT INDIA | SANOFI INDIA/ ABBOTT INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 36.5 | 35.1 | 103.8% | View Chart |
P/BV | x | 6.9 | 9.1 | 75.8% | View Chart |
Dividend Yield | % | 0.6 | 0.8 | 72.6% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
SANOFI INDIA Dec-17 |
ABBOTT INDIA Mar-18 |
SANOFI INDIA/ ABBOTT INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 4,945 | 6,110 | 80.9% | |
Low | Rs | 3,901 | 3,996 | 97.6% | |
Sales per share (Unadj.) | Rs | 1,081.8 | 1,552.2 | 69.7% | |
Earnings per share (Unadj.) | Rs | 141.6 | 188.8 | 75.0% | |
Cash flow per share (Unadj.) | Rs | 185.9 | 196.4 | 94.7% | |
Dividends per share (Unadj.) | Rs | 33.00 | 55.00 | 60.0% | |
Dividend yield (eoy) | % | 0.7 | 1.1 | 68.5% | |
Book value per share (Unadj.) | Rs | 868.8 | 796.6 | 109.1% | |
Shares outstanding (eoy) | m | 23.03 | 21.25 | 108.4% | |
Bonus/Rights/Conversions | - | - | - | ||
Price / Sales ratio | x | 4.1 | 3.3 | 125.6% | |
Avg P/E ratio | x | 31.2 | 26.8 | 116.7% | |
P/CF ratio (eoy) | x | 23.8 | 25.7 | 92.5% | |
Price / Book Value ratio | x | 5.1 | 6.3 | 80.3% | |
Dividend payout | % | 23.3 | 29.1 | 80.0% | |
Avg Mkt Cap | Rs m | 101,862 | 107,376 | 94.9% | |
No. of employees | `000 | 3.2 | 3.3 | 97.5% | |
Total wages/salary | Rs m | 3,685 | 3,937 | 93.6% | |
Avg. sales/employee | Rs Th | 7,691.9 | 9,929.3 | 77.5% | |
Avg. wages/employee | Rs Th | 1,137.7 | 1,185.1 | 96.0% | |
Avg. net profit/employee | Rs Th | 1,006.5 | 1,207.7 | 83.3% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 24,914 | 32,985 | 75.5% | |
Other income | Rs m | 807 | 1,170 | 69.0% | |
Total revenues | Rs m | 25,721 | 34,155 | 75.3% | |
Gross profit | Rs m | 5,372 | 5,245 | 102.4% | |
Depreciation | Rs m | 1,022 | 162 | 631.3% | |
Interest | Rs m | 11 | 38 | 28.8% | |
Profit before tax | Rs m | 5,146 | 6,215 | 82.8% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 1,886 | 2,203 | 85.6% | |
Profit after tax | Rs m | 3,260 | 4,012 | 81.3% | |
Gross profit margin | % | 21.6 | 15.9 | 135.6% | |
Effective tax rate | % | 36.6 | 35.4 | 103.4% | |
Net profit margin | % | 13.1 | 12.2 | 107.6% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 14,432 | 22,655 | 63.7% | |
Current liabilities | Rs m | 6,010 | 6,681 | 90.0% | |
Net working cap to sales | % | 33.8 | 48.4 | 69.8% | |
Current ratio | x | 2.4 | 3.4 | 70.8% | |
Inventory Days | Days | 61 | 65 | 94.0% | |
Debtors Days | Days | 28 | 29 | 97.7% | |
Net fixed assets | Rs m | 7,991 | 835 | 956.5% | |
Share capital | Rs m | 230 | 213 | 108.4% | |
"Free" reserves | Rs m | 19,778 | 16,715 | 118.3% | |
Net worth | Rs m | 20,008 | 16,928 | 118.2% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 27,770 | 24,162 | 114.9% | |
Interest coverage | x | 468.8 | 163.7 | 286.4% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0.9 | 1.4 | 65.7% | |
Return on assets | % | 11.8 | 16.8 | 70.3% | |
Return on equity | % | 16.3 | 23.7 | 68.7% | |
Return on capital | % | 25.8 | 36.9 | 69.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 6,306 | 369 | 1,711.1% | |
Fx outflow | Rs m | 5,257 | 3,807 | 138.1% | |
Net fx | Rs m | 1,049 | -3,438 | -30.5% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 4,351 | 1,527 | 284.9% | |
From Investments | Rs m | -787 | -2,148 | 36.6% | |
From Financial Activity | Rs m | -1,884 | -1,024 | 183.9% | |
Net Cashflow | Rs m | 1,680 | -1,646 | -102.1% |
Indian Promoters | % | 0.0 | 0.0 | - | |
Foreign collaborators | % | 60.4 | 75.0 | 80.5% | |
Indian inst/Mut Fund | % | 14.4 | 7.9 | 182.3% | |
FIIs | % | 14.6 | 0.1 | 14,600.0% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 10.5 | 17.1 | 61.4% | |
Shareholders | 15,184 | 18,270 | 83.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare SANOFI INDIA With: ALEMBIC LTD SUN PHARMA PIRAMAL ENTERPRISES FDC LTD. AUROBINDO PHARMA
Compare SANOFI INDIA With: ACTAVIS (US) ADCOCK INGRAM (S. Africa) MYLAN (US) TEVA PHARMA (Israel)
| |
Corporate governance issues with certain companies, uncertainty surrounding national elections and global issues like trade wars, Brexit, have taken a toll on the Indian markets.
For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended September 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 0.1% YoY). Sales on the other hand came in at Rs 10 bn (up 5.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended September 2018, SANOFI INDIA has posted a net profit of Rs 1 bn (up 2.5% YoY). Sales on the other hand came in at Rs 7 bn (up 11.4% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.
For the quarter ended June 2018, ABBOTT INDIA has posted a net profit of Rs 824 m (up 70.8% YoY). Sales on the other hand came in at Rs 8 bn (up 18.2% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.
For the quarter ended June 2018, SANOFI INDIA has posted a net profit of Rs 996 m (up 35.1% YoY). Sales on the other hand came in at Rs 7 bn (up 13.8% YoY). Read on for a complete analysis of SANOFI INDIA's quarterly results.
More Views on NewsThe real estate sector is ready to make a comeback. This is the stock to consider buying.
During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.
Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.
Two questions I have been eagerly waiting to ask you ever since Budget 2019 was announced.
Why its great news that prices for small caps over the last few days have been falling like there's no tomorrow.
More
| |